Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

Epic Investment Partners Views: The Week Ahead

US inflation data and key economic data will have markets on tenterhooks through the week ahead. We also have a number of US banks reporting earnings this week. Later today we will have updates from the ECB’s Lane and Rehn. On Tuesday US PPI will command market attention, and we will hear from the Fed’s Williams and Schmidt, and the ECB’s Holzmann, Vujcic and Matolcsy. Eurozone industrial production, UK CPI, and US CPI and Empire manufacturing are due on Wednesday. The Fed’s Williams, Barkin and Goolsbee all speak at separate events. US retail sales and jobless claims will hit the screens on Thursday and we have the ECB minutes from the December meeting. A busy Friday kicks-off with China GDP, property prices, retail sales and industrial production data. US housing starts and industrial production will be of interest later in the day. 

Last week “tarrified” markets witnessed all manner of highs and lows as the uncertain messaging regarding US tariffs hit the newswires on Monday. Later we had some mixed rhetoric from the Fed, though the broader message was one of caution amid upside inflation risks resulting from potential policies enacted by the Trump Administration. US economic data through the week proved broadly strong, with jobs and services surprising to the upside  

Following the robust US ISM services survey print, coupled with the upbeat JOLTS jobs data, US Treasury yields soared, sending ripples through global markets. The resurgence of the risk premium amid fiscal policy and interest rate concerns, rose to levels last seen in 2014. At that point, we witnessed a further drive higher in yields, particularly at the shorter-end following the stronger-than-expected US employment report. Non farm payroll added +256 jobs (exp. 165k) in December, and unemployment strengthened to 4.1% (from 4.2%). Average hourly earnings did, however, marginally ease to 0.3%mom and 3.9%yoy. So, a January pause in interest rate cuts is all but guaranteed. In fact, currently, the Fed funds are pricing the next cut as far out as June (at only a 69% chance). 

The yield on the 2-year rose 10bps to 4.38%, 10-year UST yield was up 16bps, to 4.76%, while the 30-year closed at 4.95%, 14bps higher. Equity markets were mixed through the week, the S&P Index closed ~2% lower. The dollar, a clear beneficiary, rose, the DXY Index closed 0.64% once again hitting fresh highs. Oil also enjoyed a rally, Brent crude closed 4.25% higher at $79.76pb buoyed by fresh US sanctions on Russian oil. 

Elsewhere, eurozone inflation increased to 2.4% in December, the third consecutive monthly rise, tempering expectations for a significant interest rate cut by the ECB. While the ECB is still expected to reduce its benchmark deposit rate by 25bps at its January 30 meeting, the higher inflation figure has diminished the likelihood of a larger 50bps reduction. 

This morning’s trade data for China surprised to the upside with exports rising 10.7% in December, and imports returned to positive growth for the first time since July. The nation’s trade surplus neared a record USD 1tn as manufacturers adjusted to changing market conditions ahead of the arrival of the Trump administration. While Chinese authorities maintained currency stability through careful management of the USDCNY fixing and offshore liquidity, persistent deflationary pressures remained evident with 27 consecutive months of PPI decline through December 2024. In response, China’s government outlined a more proactive fiscal approach for 2025. 


Epic Investment Partner’s Key risks & Disclaimers:

EPIC Global Equity Fund (the “Fund”) is a sub-fund of EPIC Funds p.l.c. (the “Company”), which is an open-ended umbrella fund authorised in Ireland as a UCITS fund and regulated by the Central Bank of Ireland. This marketing material has been approved in the UK by EPIC Markets (UK) LLP, trading as EPIC Investment Partners, which is a limited liability partnership incorporated and registered in England and Wales under partnership OC306260 with its registered office at Audrey House, 16-20 Ely Place, London EC1N 6SN. EPIC Markets (UK) LLP is regulated by the Financial Conduct Authority. Distribution of this material and the offer of the Fund are specifically restricted in certain jurisdictions. In particular, but without limitation, neither this material nor shares in the Fund are available to US persons.

This document is for general information purposes only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. It is not a personal recommendation and it should not be regarded as a solicitation or an offer to buy or sell any shares in the Fund. This document represents the views of EPIC Investment Partners at the time of writing. It should not be construed as investment advice. Any person interested in investing in the Fund should conduct their own investigation and analysis of the Fund and should consult their own professional tax, accounting or other advisers as to the risks involved in making such an investment. Full details of the Fund’s investment objectives, investment policy and risks are set out in the Fund’s Prospectus and Supplement which, together with the Key Information Document (“KID”), are available on request and free of charge from Maples Fund Services (Ireland) Limited, 32 Molesworth Street, Dublin 2, Ireland and, in the UK, from EPIC Markets (UK) LLP, Audrey House, 16-20 Ely Place, London EC1N 6SN. Any offering of the Fund is only made on the terms of the current Prospectus, Supplement and KID. A subscription in the Fund can only be made after the provision of the KIID and should be made solely upon the information contained in the Prospectus, Supplement and KID.

An investment in the Fund is not suitable for an investor who cannot sustain a loss on their investment. There is no guarantee of the Fund’s future performance and past performance is not a reliable indicator of future performance. The value of your investment and the income derived from it can go down as well as up, and you may not get back the money you invested. The risks associated with making an investment in the Fund are described in the Prospectus and Supplement but investors should note, in particular, the following: 1) Foreign currency denominated investments are subject to fluctuations in exchange rates that could have a positive or an adverse effect on an investor’s returns. There is also a risk that currency hedging transactions for one share class may in extreme cases adversely affect the net asset value of the other share classes within the same sub-fund since there is no legal segregation between share classes; 2) The Fund is subject to the risk of the insolvency of its counterparties; and 3) Emerging market securities are subject to greater social, political, regulatory, and currency risks than developed market securities. This may impact the liquidity and value of such securities and, consequently, the value of the Fund.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from EPIC Investment Partners. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document is intended for retail clients however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

Triggers to change our pro-risk view
All News

BlackRock Commentary: Triggers to change our pro-risk view

BlackRock remain pro-risk, favoring U.S. stocks, while closely monitoring policy shifts, investor sentiment on earnings and tech valuations, and vulnerabilities like rising bond yields and corporate refinancing risks.

Epic Investment Partners Weekly Article
All News

Epic Investment Partners Views: The Week Ahead

Markets face a pivotal week with US inflation data, economic updates, and earnings reports from major banks, alongside global events including Eurozone and UK inflation figures, China’s GDP, and central bank insights, as strong US data fuels yield surges and inflation risks dominate policy discussions.

If you’re looking to save money during 2025, MeDirect has a wide range of options designed to suits the different needs and goals of customers.
All News

Saving Options in 2025 with MeDirect

If you’re looking to save money during 2025, MeDirect has a wide range of options designed to suits the different needs and goals of customers.

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 


Sign up and open your account for free, within minutes.

MeDirect_Multi-Devices-cards

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.